CRISPR Medicine News

About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.

CLINICAL TRIALS
ABCA4 Retinopathy, (NCT06467344)
Sponsors:
Ascidian Therapeutics, Inc
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Transthyretin Amyloidosis, ATTR, (NCT06539208)
Sponsors:
YolTech Therapeutics Co., Ltd
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
Harvard Medical School (@HMS)

Genome Engineering Seminar Series (GESS)

Read more...Harvard Medical School (@HMS)
Join WDC Chat Community
WDC Chat Community
CRISPR Medicine News
close
Search CRISPR Medicine